Citigroup’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-9
Closed -$2K 7848
2018
Q4
$2K Sell
9
-35
-80% -$8.81K ﹤0.01% 7525
2018
Q3
$12K Buy
44
+23
+110% +$6.92K ﹤0.01% 7298
2018
Q2
$7K Buy
+21
New +$6.92K ﹤0.01% 7287
2017
Q4
Sell
-2
Closed -$1K 7676
2017
Q3
$1K Sell
2
-83
-98% -$44.2K ﹤0.01% 7167
2017
Q2
$53K Sell
85
-38
-31% -$25.5K ﹤0.01% 5748
2017
Q1
$94K Sell
123
-52
-30% -$41.2K ﹤0.01% 5254
2016
Q4
$142K Buy
175
+88
+101% +$69.8K ﹤0.01% 5558
2016
Q3
$79K Sell
87
-32
-27% -$31.3K ﹤0.01% 5365
2016
Q2
$106K Buy
119
+64
+116% +$42.9K ﹤0.01% 5036
2016
Q1
$28K Buy
55
+9
+20% +$4.57K ﹤0.01% 6399
2015
Q4
$27K Buy
46
+42
+1,050% +$30.5K ﹤0.01% 6335
2015
Q3
$3K Buy
+4
New +$3.04K ﹤0.01% 6940

Other funds holding VIVS

Citigroup's VIVS Position: Q2 2026 in Review

Citigroup sold out of VivoSim Labs (VIVS) in Q2 2026, closing a stake of 6,504 shares — an estimated $9.3K sold.

Citigroup first reported a position in VIVS in Q3 2013 and held it in 36 quarters. The position peaked at $373K in Q4 2016. 26 funds tracked by Wall St. Rank hold VIVS as of Q2 2026.

  • Citigroup reported no remaining VivoSim Labs position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 6,504 VivoSim Labs shares in Q2 2026, an estimated $9.3K.
  • Citigroup first reported a position in VivoSim Labs in Q3 2013 and held it in 36 quarters.
  • Citigroup's VivoSim Labs position peaked at $373K in Q4 2016.
  • 26 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.